Skip to main content
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2005 Dec;1(1):26–29. doi: 10.1007/BF03160902

Unusual presentation of iatrogenic phenytoin toxicity in a newborn

Jennifer A Lowry 1,2,, John C Vandover 3, Jan DeGreeff 1, Anthony J Scalzo 1
PMCID: PMC3550013  PMID: 18072100

Abstract

Background

Medication errors may produce severe toxicity resulting in hospitalization. This can be compounded if the physician obtains the wrong concentration from a reference manual and a pharmacy miscalculates the conversion. We report a child presenting with ileus, hypothermia and lethargy after receiving supratherapeutic dosing of phenytoin after a concentration miscalculation.

Case Report

A one-month-old infant presented to the Emergency Department with progressive worsening of abdominal distension, diminished activity, and a one day history of difficulty feeding secondary to a decreased level of consciousness. The past medical history was significant for neonatal Group B Strep meningitis with seizures. Among the child’s discharge medications was a prescription for phenytoin (30 mg/5 mL) 2.5 cc by mouth three times daily. On exam, the child was hypothermic with pink mottled skin, poor responsiveness, prolonged capillary refill, abdominal distension with hypoactive bowel sounds, and a dysconjugate gaze. The Initial phenytoin serum concentration was 91.8 mcg/mL. She was admitted to the PICU and was started on ampicillin and cefotaxime for R/O sepsis. Phenytoin was withheld and subsequent serum concentrations revealed an extremely slow elimination (mcg/mL vs. time pair coordinates were 78.2/13.3h; 74.3/62.3h; 43.7/109.6h; 10.8/160.9h) reflecting zero-order kinetics. Post discontinuing antibiotics, phenytoin levels decreased at rates expected. She was discharged after resolution of symptoms. The MD who had written the phenytoin prescription had based it on theHarriet Lane Handbook, 2000 Ed. The 30 mg/5 mL formulation has been unavailable in the US for several years. A community pharmacy substituted the 125 mg/5 mL formulation, but miscalculated the dosage to be 1.6 cc (40 mg) tid.

Conclusions

Abdominal distension and ileus may be presenting symptoms in children at toxic phenytoin levels. Ampicillin and cefotaxime may effect the elimination rate of phenytoin at such levels. We report one of the highest phenytoin levels recorded after therapeutic misadventure. Physicians must be aware of inaccuracies in reference manuals that may result in dosing errors.

Keywords: phenytoin, drug toxicity

Full Text

The Full Text of this article is available as a PDF (130.9 KB).

References

  • 1.Anonymous. American Academy of Pediatrics: Committee on Drugs and Committee on Hospital Care. Pediatrics.1998;102:428.
  • 2.Sharfstein J, Agrawal D, Jeffrey P. Letter to the editor. Pediatrics. 1998;102:1223–1223. doi: 10.1542/peds.102.5.1223. [DOI] [PubMed] [Google Scholar]
  • 3.Wyte C, Berk WA. Severe oral phenytoin overdose does not cause cardiovascular mortality. Ann Emerg Med. 1991;20:508–508. doi: 10.1016/S0196-0644(05)81604-X. [DOI] [PubMed] [Google Scholar]
  • 4.Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (Part II) Clin Pharmacokinet. 1990;18:131–131. doi: 10.2165/00003088-199018020-00004. [DOI] [PubMed] [Google Scholar]
  • 5.Sarich T, Wright JM. Hypothyroxinemia and phenytoin toxicity: A vicious circle. Drug Metabol Drug Interact. 1996;13:155–155. doi: 10.1515/dmdi.1996.13.2.155. [DOI] [PubMed] [Google Scholar]
  • 6.Zhu SQ, Liu XM, Ruan XZ, Cai Z. Changes of thyroid hormone levels in epileptic patients. J Tongji Med Univ. 1994;14:119–119. [PubMed] [Google Scholar]
  • 7.Bassotti G, Pagliacci MC, Nicoletti I, Pelli MA, Morelli A. Intestinal pseudo-obstruction secondary to hypothyroidism. Importance of small bowel manometry. J Clin Gastroenterol. 1992;14:56–56. doi: 10.1097/00004836-199201000-00014. [DOI] [PubMed] [Google Scholar]
  • 8.Goto S, Billmire DF, Grosfeld JL. Hypothyroidism impairs colonic motility and function. An experimental study in the rat. Eur J Pediatr Surg. 1992;2:16–16. doi: 10.1055/s-2008-1063392. [DOI] [PubMed] [Google Scholar]
  • 9.Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Clin Pharmacokinet. 1995;29:341–341. doi: 10.2165/00003088-199529050-00004. [DOI] [PubMed] [Google Scholar]
  • 10.Painter MJ, Minnigh MB, Gaus L, Scher M, Brozanski B, Alvin J. Neonatal phenobarbital and phenytoin binding profiles. J Clin Pharmacol. 1994;34:312–312. doi: 10.1002/j.1552-4604.1994.tb01999.x. [DOI] [PubMed] [Google Scholar]
  • 11.Leeder JS, Kearns GL. Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am. 1997;44:55–55. doi: 10.1016/S0031-3955(05)70463-6. [DOI] [PubMed] [Google Scholar]
  • 12.Bachmann K, Schwartz JI, Forney RB, Jaurgeui L. Single dose phenytoin clearance during erythromycin treatment. Research Communications in Chemical Pathology and Pharmacology. 1984;46:207–207. [PubMed] [Google Scholar]
  • 13.Tucker RM, Denning DW, Hanson LH, Rinaldi MG, Graybill JR, Sharkey PK, et al. Interaction of azoles with rifampin, phenytoin, and carbamazepine: In vitro and clinical observations. Clin Infect Dis. 1992;14:165–165. doi: 10.1093/clinids/14.1.165. [DOI] [PubMed] [Google Scholar]
  • 14.Rose JQ, Choi HK, Schentag JJ, Kinkel WR, Jusko WJ. Intoxication caused by interaction of chloramphenicol and phenytoin. JAMA. 1977;237:2630–2630. doi: 10.1001/jama.237.24.2630. [DOI] [PubMed] [Google Scholar]
  • 15.Bint AJ, Burtt I. Adverse antiobiotic drug interactions. Drugs. 1980;20:57–57. doi: 10.2165/00003495-198020010-00004. [DOI] [PubMed] [Google Scholar]
  • 16.Chandra RS, Dalvi SS, Powar HS, Karnad PD, Kshirsagar NA. Phenytoin toxicity due to rifampicin induced hepatic dysfunction. JAPI. 1993;41:536–536. [PubMed] [Google Scholar]
  • 17.Dasgupta A, Dennen DA, Dean R, McLawhorn RW. Displacement of phenytoin from serum protein carriers by antibiotics: Studies with ceftriaxone, nafcillin, and sulfamethoxazole. Clin Chem. 1991;37:98–98. [PubMed] [Google Scholar]
  • 18.Dasgupta A, Sperelakis A, Mason A, Dean R. Phenytoin-oxacillin interactions in normal and uremic sera. Pharmacother. 1997;17:375–375. [PubMed] [Google Scholar]
  • 19.Arimori K, Nakano M, Otagiri M, Uekama K. Effects of penicillins on binding of phenytoin to plasma proteins in vitro and in vivo. Biopharm Drug Dispos. 1984;5:219–27. doi: 10.1002/bdd.2510050304. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES